Protega Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROTEGA PHARMS
PROTEGA PHARMS has one approved drug.
There are two US patents protecting PROTEGA PHARMS drugs.
Summary for Protega Pharms
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Protega Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-003 | Apr 20, 2017 | RX | No | No | 7,955,619 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-001 | Apr 20, 2017 | RX | No | No | 10,314,788 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-004 | Sep 5, 2024 | RX | No | No | 7,955,619 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-004 | Sep 5, 2024 | RX | No | No | 10,314,788 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-002 | Apr 20, 2017 | RX | No | No | 10,314,788 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Protega Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2696341 | ⤷ Start Trial |
| Poland | 2187873 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010019279 | ⤷ Start Trial |
| Canada | 2923102 | ⤷ Start Trial |
| Mexico | 2010001812 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Protega Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
